Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
California Institute of Technology
Headquarters: Pasadena, CA, United States of America
Website: http://www.caltech.edu
Year Founded: 1891
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Sep 26, 2024
Discovery & Translation
Science Spotlight: Targeted protein relocalization, rejuvenating aged eggs, and more
BioCentury’s roundup of translational innovations
BioCentury | May 18, 2024
Discovery & Translation
Brain-penetrant AAV capsid progress at ASGCT
Companies and academics showcase two approaches to make AAV capsids with enhanced brain targeting and suppressed liver targeting
BioCentury | Jul 15, 2023
Discovery & Translation
Armgo molecule prevents cardiogenic dementia; Ten63’s improved HIV-1 Abs and more
BioCentury’s roundup of translational innovations
BioCentury | May 12, 2023
Discovery & Translation
Adding diversity to the human reference genome; SNIPR’s phage and more
BioCentury’s roundup of translational news
BioCentury | Apr 28, 2023
Discovery & Translation
MMP3 gene therapy for glaucoma; plus programmable mRNA translation and more
BioCentury’s roundup of translational news
BioCentury | May 20, 2022
Discovery & Translation
Optimizing CNS tropism for AAVs at ASGCT
Directed evolution, genetic library screening and peptide modifications were the most common strategies presented
BioCentury | May 4, 2022
Finance
Newcomer Catalio builds momentum with $381M biotech venture fund
Firm’s model attracts top academics for company creation
BioCentury | Apr 1, 2022
Discovery & Translation
An in vivo CAR T manufacturing implant; plus Seer, Kither and more
BioCentury’s roundup of translational news
BioCentury | Dec 22, 2021
Management Tracks
Nobel winning chemist Grubbs passes
Longtime Caltech professor served on Aileron’s SAB
BioCentury | Dec 10, 2021
Discovery & Translation
New approaches to HIV prevention; plus Abpro, Capsida and more
BioCentury’s roundup of translational news
Items per page:
1 - 10 of 172